3KQ-19302-02113
2 vaccinations
2 coded responses
18 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 070 / NJ
- Registered
- 2021-02-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-23
Registered in v-safe
-
2021-02-23
Dose 1 — Pfizer-BioNTech
- 2021-02-24
- 2021-02-25
- 2021-03-01
- 2021-03-04
- 2021-03-11
-
2021-03-16
Dose 2 — Pfizer-BioNTech
-
2021-03-16
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · None · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-03-19
- 2021-03-20
- 2021-03-23
-
2021-03-30
Survey response — day 14, dose 2MedDRA: Nasopharyngitis — Feeling: Good · Be unable to workFree text: Symptoms consistent with common coldMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
- 2021-04-13
- 2021-04-22
- 2021-04-27
- 2021-06-15
- 2021-09-14
-
2022-03-16
Survey response — 12 months, dose 2MedDRA: Peritonsillar abscess, Streptococcal infection, Tonsillitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Strep, tonsillitis, tonsil abcessMedDRA releases: 2024-11 · check-in free text available
-
2022-03-16
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-23 | Pfizer-BioNTech | |
| 2 | 2021-03-16 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-16 | Unsuccessful |
Free text
Release 6 — day 14, dose 2
Symptoms: Symptoms consistent with common cold
Release 11 — 12 months, dose 2
Symptoms: Strep, tonsillitis, tonsil abcess
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Peritonsillar abscess | · | · | ✓ |
| SD | Streptococcal infection | · | · | ✓ |
| SD | Tonsillitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release